Table 1.
Summary of Clinical Characteristics of GBM Patients Who Received Standard Treatment
| Characteristics | All Patients, N = 194 |
|---|---|
| Age, years | |
| Median | 55 |
| Range | 19–80 |
| Clinical history, days | |
| Median | 20 |
| Range | 1–365 |
| Sex, n (%) | |
| Male | 115(59.3) |
| Female | 79(40.7) |
| Size, cm, n (%) | |
| ≤5 | 123(63.4) |
| >5 | 71(36.6) |
| First presenting symptoms, n (%) | |
| Seizures | 22(11.4) |
| Others | 172(88.6) |
| Tumor location, n (%) | |
| Frontal | 45(23.2) |
| Temporal | 43(22.2) |
| Mixed | 69(35.6) |
| Others | 37(19.1) |
| NLR, median (IQR) | 2.37 (1.69–4.19) |
| PLR, median (IQR) | 130.04 (93.42–174.22) |
| LMR, median (IQR) | 3.47 (2.63–4.73) |
| PNI, median (IQR) | 50.0 (47.2–53.6) |
| AGR, median (IQR) | 1.75 (1.53–1.98) |
| RDW, %, median (IQR) | 13.3 (12.8–13.9) |
| GLC, mmol/L, median (IQR) | 4.97 (4.48–5.75) |
| LDH, U/L, median (IQR) | 176 (157–200) |
| FIB, g/L, median (IQR) | 3.01 (2.55–3.65) |
| DD, mg/L, median (IQR) | 0.11 (0.08–0.17) |
| OS, months | |
| Median | 16 |
| Range | 3-41 |
| Survival Status, n (%) | |
| Alive | 60(30.9) |
| Dead | 134(69.1) |
Abbreviations: NLR, the neutrophil-to-lymphocyte ratio; PLR, the platelet-to-lymphocyte ratio; LMR, the lymphocyte -to- monocyte ratio; PNI, the prognostic nutrition index; AGR, albumin-to-globulin ratio; RDW, red blood cell distribution width; GLC, glucose; LDH, lactate dehydrogenase; FIB, fibrinogen; DD, D-dimer; IQR, interquartile range; OS, overall survival.